{"id":"https://openalex.org/W3107176331","doi":"https://doi.org/10.1021/acs.joc.0c02291","title":"Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing","display_name":"Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing","publication_year":2020,"publication_date":"2020-11-30","ids":{"openalex":"https://openalex.org/W3107176331","doi":"https://doi.org/10.1021/acs.joc.0c02291","mag":"3107176331","pmid":"https://pubmed.ncbi.nlm.nih.gov/33253568","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8154579"},"language":"en","primary_location":{"id":"doi:10.1021/acs.joc.0c02291","doi":"https://doi.org/10.1021/acs.joc.0c02291","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.joc.0c02291","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c02291","source":{"id":"https://openalex.org/S205050996","display_name":"The Journal of Organic Chemistry","issn_l":"0022-3263","issn":["0022-3263","1520-6904"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Organic Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c02291","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077559342","display_name":"Benjamin I. Andrews","orcid":"https://orcid.org/0000-0002-7852-3675","observed_orcids":["https://orcid.org/0000-0002-7852-3675"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Benjamin I. Andrews","raw_affiliation_strings":["Chemical Development, GlaxoSmithKline, Stevenage SG1 2NY, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-7852-3675","affiliations":[{"raw_affiliation_string":"Chemical Development, GlaxoSmithKline, Stevenage SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026843278","display_name":"Firoz D. Antia","orcid":"https://orcid.org/0000-0001-7960-4277","observed_orcids":["https://orcid.org/0000-0001-7960-4277"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Firoz D. Antia","raw_affiliation_strings":["Biogen, Inc., Cambridge, Massachusetts 02142, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen, Inc., Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028287351","display_name":"Shawn B. Brueggemeier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn B. Brueggemeier","raw_affiliation_strings":["Bristol-Myers Squibb, New Brunswick, New Jersey 08901, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, New Brunswick, New Jersey 08901, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037369709","display_name":"Louis J. Diorazio","orcid":"https://orcid.org/0000-0001-8017-9167","observed_orcids":["https://orcid.org/0000-0001-8017-9167"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Louis J. Diorazio","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 4TF, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 4TF, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003949218","display_name":"Stefan G. Koenig","orcid":"https://orcid.org/0000-0002-1878-614X","observed_orcids":["https://orcid.org/0000-0002-1878-614X"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan G. Koenig","raw_affiliation_strings":["Genentech, Inc., A Member of the Roche Group, South San Francisco, California 94080, United States"],"raw_orcid":"https://orcid.org/0000-0002-1878-614X","affiliations":[{"raw_affiliation_string":"Genentech, Inc., A Member of the Roche Group, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I129302853","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003388489","display_name":"Michael E. Kopach","orcid":"https://orcid.org/0000-0002-3590-702X","observed_orcids":["https://orcid.org/0000-0002-3590-702X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Kopach","raw_affiliation_strings":["Eli Lilly and Company, 1400 West Raymond Street, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, 1400 West Raymond Street, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107906793","display_name":"Heewon Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heewon Lee","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Martin Olbrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin Olbrich","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022765127","display_name":"Anna Watson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna L. Watson","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 4TF, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 4TF, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5077559342"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":3.1415,"has_fulltext":false,"cited_by_count":156,"citation_normalized_percentile":{"value":0.93374197,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"86","issue":"1","first_page":"49","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/green-chemistry","display_name":"green chemistry","score":0.7839999794960022},{"id":"https://openalex.org/keywords/sustainable-pharmaceutical-manufacturing","display_name":"sustainable pharmaceutical manufacturing","score":0.5870000123977661},{"id":"https://openalex.org/keywords/oligonucleotide-synthesis","display_name":"oligonucleotide synthesis","score":0.7559999823570251},{"id":"https://openalex.org/keywords/oligonucleotide-purification","display_name":"oligonucleotide purification","score":0.8420000076293945},{"id":"https://openalex.org/keywords/process-mass-intensity","display_name":"process mass intensity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/energy-intensive-processes","display_name":"energy-intensive processes","score":0.7720000147819519},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.7409999966621399},{"id":"https://openalex.org/keywords/university-industry-collaboration","display_name":"university-industry collaboration","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C66204764","wikidata":"https://www.wikidata.org/wiki/Q219416","display_name":"Sustainability","level":2,"score":0.6486776471138},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.4749341607093811},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4473614990711212},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4435507655143738},{"id":"https://openalex.org/C68804670","wikidata":"https://www.wikidata.org/wiki/Q2620256","display_name":"Oligonucleotide synthesis","level":4,"score":0.43239572644233704},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4300985038280487},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.32653942704200745},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2792235016822815},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.25582197308540344},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15310296416282654},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.joc.0c02291","doi":"https://doi.org/10.1021/acs.joc.0c02291","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.joc.0c02291","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c02291","source":{"id":"https://openalex.org/S205050996","display_name":"The Journal of Organic Chemistry","issn_l":"0022-3263","issn":["0022-3263","1520-6904"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Organic Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8154579","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8154579","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Org Chem","raw_type":"Text"},{"id":"pmid:33253568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33253568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of organic chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.joc.0c02291","doi":"https://doi.org/10.1021/acs.joc.0c02291","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.joc.0c02291","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c02291","source":{"id":"https://openalex.org/S205050996","display_name":"The Journal of Organic Chemistry","issn_l":"0022-3263","issn":["0022-3263","1520-6904"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Organic Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Responsible consumption and production","score":1.0,"id":"https://metadata.un.org/sdg/12"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308355","display_name":"American Chemical Society","ror":"https://ror.org/059dqb057"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3107176331.pdf"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1523818626","https://openalex.org/W1793575896","https://openalex.org/W1850939658","https://openalex.org/W1897277771","https://openalex.org/W1984599128","https://openalex.org/W1991975352","https://openalex.org/W2005799039","https://openalex.org/W2019250389","https://openalex.org/W2022576356","https://openalex.org/W2027094517","https://openalex.org/W2030576773","https://openalex.org/W2053632726","https://openalex.org/W2073262653","https://openalex.org/W2074614836","https://openalex.org/W2076964970","https://openalex.org/W2077584118","https://openalex.org/W2080447227","https://openalex.org/W2080521516","https://openalex.org/W2081746459","https://openalex.org/W2087913246","https://openalex.org/W2125803253","https://openalex.org/W2132260670","https://openalex.org/W2142191207","https://openalex.org/W2148071200","https://openalex.org/W2319156585","https://openalex.org/W2334828163","https://openalex.org/W2481500357","https://openalex.org/W2557512586","https://openalex.org/W2592524531","https://openalex.org/W2594133976","https://openalex.org/W2597578550","https://openalex.org/W2746807303","https://openalex.org/W2808129035","https://openalex.org/W2886057302","https://openalex.org/W2886572205","https://openalex.org/W2892338260","https://openalex.org/W2893168313","https://openalex.org/W2896349650","https://openalex.org/W2901966955","https://openalex.org/W2926626251","https://openalex.org/W2928506363","https://openalex.org/W2952711909","https://openalex.org/W2997888707","https://openalex.org/W3023447766","https://openalex.org/W4238437151"],"related_works":["https://openalex.org/W4403547213","https://openalex.org/W7115185504","https://openalex.org/W4394728090","https://openalex.org/W4417334008","https://openalex.org/W2132260670","https://openalex.org/W4286781129","https://openalex.org/W7196959610","https://openalex.org/W4405475603","https://openalex.org/W2913143997","https://openalex.org/W2928506363"],"abstract_inverted_index":{"With":[0,29],"a":[1,57,112,117,122],"renewed":[2],"and":[3,38,44,59,74,84,132,154,159,167,170],"growing":[4],"interest":[5],"in":[6,41,53,81,150],"therapeutic":[7],"oligonucleotides":[8],"across":[9],"the":[10,23,34,47,51,88,100,119,126,147,171],"pharmaceutical":[11,172],"industry,":[12],"pressure":[13],"is":[14],"increasing":[15],"on":[16],"drug":[17],"developers":[18],"to":[19,36,62,189],"take":[20],"more":[21,40,140],"seriously":[22],"sustainability":[24],"ramifications":[25],"of":[26,50,68,71,102,128,177],"this":[27,143],"modality.":[28],"12":[30],"oligonucleotide":[31,54,106,138,151,196],"drugs":[32],"reaching":[33],"market":[35],"date":[37],"hundreds":[39],"clinical":[42],"trials":[43],"preclinical":[45],"development,":[46],"current":[48,195],"state":[49],"art":[52],"production":[55,139],"poses":[56],"waste":[58],"cost":[60],"burden":[61],"manufacturers.":[63],"Legacy":[64],"technologies":[65],"make":[66,137],"use":[67],"large":[69],"volumes":[70],"hazardous":[72],"reagents":[73],"solvents,":[75],"as":[76,78,111],"well":[77],"energy-intensive":[79],"processes":[80,104],"synthesis,":[82,152],"purification,":[83,153],"isolation.":[85],"In":[86,142],"2016,":[87],"American":[89],"Chemical":[90],"Society":[91],"(ACS)":[92],"Green":[93],"Chemistry":[94],"Institute":[95],"Pharmaceutical":[96,108],"Roundtable":[97,120],"(GCIPR)":[98],"identified":[99],"development":[101,166],"greener":[103],"for":[105,194],"Active":[107],"Ingredients":[109],"(APIs)":[110],"critical":[113,175],"unmet":[114],"need.":[115],"As":[116],"result,":[118],"formed":[121],"focus":[123],"team":[124],"with":[125],"remit":[127],"identifying":[129],"green":[130],"chemistry":[131],"engineering":[133],"improvements":[134],"that":[135],"would":[136],"sustainable.":[141],"Perspective,":[144],"we":[145],"summarize":[146],"present":[148],"challenges":[149],"isolation;":[155],"highlight":[156],"potential":[157],"solutions;":[158],"encourage":[160],"synergies":[161],"between":[162],"academia;":[163],"contract":[164],"research,":[165],"manufacturing":[168,197],"organizations;":[169],"industry.":[173],"A":[174],"part":[176],"our":[178],"assessment":[179],"includes":[180],"Process":[181],"Mass":[182],"Intensity":[183],"(PMI)":[184],"data":[185],"from":[186],"multiple":[187],"companies":[188],"provide":[190],"preliminary":[191],"baseline":[192],"metrics":[193],"processes.":[198]},"counts_by_year":[{"year":2026,"cited_by_count":28},{"year":2025,"cited_by_count":47},{"year":2024,"cited_by_count":44},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-12-07T00:00:00"}